SPECT Study With SB-773812 In Schizophrenic Patients
Clinical trial NCT00269035 · COMPLETED
Trial details
- NCT number
- NCT00269035
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-21
- Primary completion
- 2007-05-26
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.